Harry Wanebo

976 total citations
7 papers, 707 citations indexed

About

Harry Wanebo is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harry Wanebo has authored 7 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Otorhinolaryngology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harry Wanebo's work include Head and Neck Cancer Studies (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and CAR-T cell therapy research (2 papers). Harry Wanebo is often cited by papers focused on Head and Neck Cancer Studies (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and CAR-T cell therapy research (2 papers). Harry Wanebo collaborates with scholars based in United States and Canada. Harry Wanebo's co-authors include Martín C. Mihm, William R. Jewell, Constantine P. Karakousis, Seng‐Jaw Soong, Walley Temple, Raymond L. Barnhill, Marshall M. Urist, M. I. Ross, Merrick I. Ross and R A Desmond and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Surgical Oncology and American Journal of Clinical Oncology.

In The Last Decade

Harry Wanebo

7 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry Wanebo United States	6	611	250	195	105	86	7	707
R Howman-Giles Australia	9	579 0.9×	283 1.1×	87 0.4×	46 0.4×	118 1.4×	16	710
N A Fenske United States	5	507 0.8×	270 1.1×	71 0.4×	47 0.4×	141 1.6×	9	595
A. Schoengen Germany	12	557 0.9×	227 0.9×	160 0.8×	56 0.5×	103 1.2×	44	661
Charles Cox United States	5	539 0.9×	253 1.0×	84 0.4×	61 0.6×	123 1.4×	10	665
Andrea Hestley United States	13	545 0.9×	305 1.2×	101 0.5×	61 0.6×	130 1.5×	15	587
K.W. Schulte Germany	13	550 0.9×	310 1.2×	225 1.2×	124 1.2×	197 2.3×	37	817
Augustinus P. T. van der Ploeg Netherlands	14	525 0.9×	211 0.8×	213 1.1×	99 0.9×	37 0.4×	15	613
Annette H. Chakera Denmark	14	326 0.5×	134 0.5×	68 0.3×	39 0.4×	78 0.9×	43	523
Damian Silbermins United States	6	338 0.6×	116 0.5×	82 0.4×	32 0.3×	36 0.4×	8	529
A. Tejera‐Vaquerizo Spain	15	516 0.8×	321 1.3×	147 0.8×	68 0.6×	255 3.0×	51	654

Countries citing papers authored by Harry Wanebo

Since Specialization

Citations

This map shows the geographic impact of Harry Wanebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Wanebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Wanebo more than expected).

Fields of papers citing papers by Harry Wanebo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Wanebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Wanebo. The network helps show where Harry Wanebo may publish in the future.

Co-authorship network of co-authors of Harry Wanebo

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Wanebo. A scholar is included among the top collaborators of Harry Wanebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Wanebo. Harry Wanebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Birnbaum, Ariel E., Ritesh Rathore, Priscilla Merriam, et al.. (2012). Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer. American Journal of Clinical Oncology. 37(2). 162–166. 5 indexed citations

2.

Birnbaum, Ariel E., Ritesh Rathore, Harry Wanebo, et al.. (2010). Cetuximab, Paclitaxel, Carboplatin, and Radiation For Head and Neck Cancer. American Journal of Clinical Oncology. 33(2). 144–147. 14 indexed citations

3.

Balch, Charles M., Seng‐Jaw Soong, Thomas J. Smith, et al.. (2001). Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1?4 mm Melanomas. Annals of Surgical Oncology. 8(2). 101–108. 268 indexed citations

4.

Soong, Seng‐Jaw, M. I. Ross, Marshall M. Urist, et al.. (2000). Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm). Annals of Surgical Oncology. 7(2). 87–97. 340 indexed citations

5.

Safran, Howard, Harry Wanebo, Paul J. Hesketh, et al.. (2000). Paclitaxel and concurrent radiation for gastric cancer. International Journal of Radiation Oncology*Biology*Physics. 46(4). 889–894. 26 indexed citations

6.

Glicksman, Arvin S., Gus J. Slotman, Jeffrey W. Clark, et al.. (1994). Concurrent CIS-platinum and radiation with or without surgery for advanced head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 30(5). 1043–1050. 52 indexed citations

7.

Hirshaut, Yashar, Carl Pinsky, Harry Wanebo, & David W. Braun. (1984). Corynebacterium parvum toxicity in patients with limited and advanced malignancy. European Journal of Cancer and Clinical Oncology. 20(5). 583–591. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact